Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enric Carreras

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
Transplantation and Cellular Therapy|October 20, 2025
Modifying Post-Transplant Cyclophosphamide Platform to Improve Safety in HLA-Matched Allogeneic HCT: A Reduced Dose Plus Adjunctive StrategiesFilipe R Pinto, María Queralt Salas, María Suárez-Lledó, et al.
Journal for Immunotherapy of Cancer|April 12, 2023
Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosisAna Belen Moreno-Castaño, Sara Fernández, Helena Ventosa, et al.
Shock (Augusta, Ga.)|June 26, 2021
Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic SyndromesSara Fernández, Ana B Moreno-Castaño, Marta Palomo, et al.
Frontiers in Immunology|June 30, 2026
Endothelial cell damage in patients with acute graft versus host disease receiving treatment with extracorporeal photopheresisJulia Martinez-Sanchez, Paola Charry, Ana Belén Moreno-Castaño, et al.
American Journal of Obstetrics and Gynecology|March 30, 2022
Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancyMarta Palomo, Lina Youssef, Alex Ramos, et al.
Cancer Treatment and Research Communications|April 11, 2025
At-home autologous hematopoietic cell transplant for adults with hematological malignancies. How frailty impacts and evolves during HCT procedure. An observational, longitudinal, and prospective studyJuan Ortiz, María Teresa Solano, Cristina Gallego, et al.
British Journal of Haematology|May 30, 2020
Complement as the enabler of carfilzomib-induced thrombotic microangiopathyMiquel Blasco, Alexandra Martínez-Roca, Luis G Rodríguez-Lobato, et al.
Transplantation and Cellular Therapy|May 16, 2022
PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCTMaría Queralt Salas, Paola Charry, Alexandra Pedraza, et al.
Transplantation and Cellular Therapy|December 2, 2023
Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than LimitationsMaría Queralt Salas, Alexandra Pedraza, Paola Charry, et al.
Blood|August 30, 2002
Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasiaJorge Sierra, Waleska S Pérez, Ciril Rozman, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Transplantation and Cellular Therapy|October 20, 2025
Modifying Post-Transplant Cyclophosphamide Platform to Improve Safety in HLA-Matched Allogeneic HCT: A Reduced Dose Plus Adjunctive StrategiesFilipe R Pinto, María Queralt Salas, María Suárez-Lledó, et al.
Journal for Immunotherapy of Cancer|April 12, 2023
Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosisAna Belen Moreno-Castaño, Sara Fernández, Helena Ventosa, et al.
Shock (Augusta, Ga.)|June 26, 2021
Distinctive Biomarker Features in the Endotheliopathy of COVID-19 and Septic SyndromesSara Fernández, Ana B Moreno-Castaño, Marta Palomo, et al.
Frontiers in Immunology|June 30, 2026
Endothelial cell damage in patients with acute graft versus host disease receiving treatment with extracorporeal photopheresisJulia Martinez-Sanchez, Paola Charry, Ana Belén Moreno-Castaño, et al.
American Journal of Obstetrics and Gynecology|March 30, 2022
Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancyMarta Palomo, Lina Youssef, Alex Ramos, et al.
Cancer Treatment and Research Communications|April 11, 2025
At-home autologous hematopoietic cell transplant for adults with hematological malignancies. How frailty impacts and evolves during HCT procedure. An observational, longitudinal, and prospective studyJuan Ortiz, María Teresa Solano, Cristina Gallego, et al.
British Journal of Haematology|May 30, 2020
Complement as the enabler of carfilzomib-induced thrombotic microangiopathyMiquel Blasco, Alexandra Martínez-Roca, Luis G Rodríguez-Lobato, et al.
Transplantation and Cellular Therapy|May 16, 2022
PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCTMaría Queralt Salas, Paola Charry, Alexandra Pedraza, et al.
Transplantation and Cellular Therapy|December 2, 2023
Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than LimitationsMaría Queralt Salas, Alexandra Pedraza, Paola Charry, et al.
Blood|August 30, 2002
Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasiaJorge Sierra, Waleska S Pérez, Ciril Rozman, et al.
Pageof 15